Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

In two GLP compliant OECD TG (439 & 431) the skin irritation and corrosion potency of the test item was evaluated. Further, OECD TG 437 and 405 were performed to evaluate the eye irritation potential.


Within the OECD TG 439, a viability measured via MTT assay of 45.7 % obtained. To to this result, the test item is considered as skin irritant Category 1 or 2 and a subsequent in vitro assay to elucidate the category (OECD TG 431) was performed.


 

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
16 December 2020 To 29 March 2021
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
OECD 439
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Principles of method if other than guideline:
To evaluate the skin irritation potential of Mo10V3TeNbO42 using Reconstructed Human Epidermal Model - EpiDerm™ (EPI-200- SIT).
GLP compliance:
yes (incl. QA statement)
Remarks:
With GLP Certificate
Specific details on test material used for the study:
Physical Appearance (with color): Solid (black)
Batch No.: EX.14402.600
Date of Manufacture: Oct 2017
Date of Expiry: No change of properties known over time (endless)
Storage Conditions: Ambient (21 to 29ºC)
Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
other: MatTek In vitro Life Science Laboratories, s.r.o, MlynskéNivy 73, 821 05, Bratislava II, Slovak Republic, www.mattek.com; Phone: +421-2-3260-7401; Fax: +421-2-3260-7404.
Justification for test system used:
As recommended in OECD Guideline No. 439, Reconstructed Human Epidermal Model EpiDerm™ (EPI-200-SIT) has been selected as test system for in vitro skin irritation.
Vehicle:
unchanged (no vehicle)
Details on test system:
The Reconstructed Human Epidermal Model - EpiDerm™ (EPI-200-SIT) was used as test system
Control samples:
yes, concurrent negative control
Amount/concentration applied:
Quantity of 30 µL of DPBS (NC) and 5% SDS (PC) were dispensed directly atop the tissue at 1 minute intervals to facilitate rinsing of the NC and PC after exposure.

The tissues were exposed to 25 mg of test item.
Duration of treatment / exposure:
1 hour and 48 hours
Duration of post-treatment incubation (if applicable):
Percentage viability of tissues was measured by performing MTT assay after 60 minutes of treatment and post incubation of 43 hours and 7 minutes.
Number of replicates:
3
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean of three replicates
Value:
45.7
Vehicle controls validity:
not examined
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Other effects / acceptance of results:
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Acceptance criteria met for variability between replicate measurements: yes
Interpretation of results:
Category 2 (irritant) based on GHS criteria
Conclusions:
Based on the results obtained under the laboratory testing conditions, the test item is categorized as irritant to Reconstructed Human Epidermis (RhE) in accordance with UN GHS (Category 2 or Category 1), as the mean percentage of tissue viability was less than 50% of the negative control after 60 minutes of exposure and 43 hours and 7 minutes post incubation.
Since a subsequent study performed according to OECD TG 431 (see chapter 7.3.1) did not justify a classification as Skin Corrosive Category 1, a justification as Skin Irritant Category in accordance with UN GHS is justified.
Executive summary:

The mean OD of the negative controltissues is 1.273 which is within the range of ≥0.8 and ≤2.8, hence the tissues were considered as viable after shipping and storing procedures and under specific conditions of use.Certificate of analysis, histology report and images of EpiDerm tissues of lot No. 33783 provided by MatTekwas provided as Annexures 3, 4 and 5 respectively. Percentage viability of tissues was measured by performing MTT assay after 60 minutes of treatment and post incubation of 43 hours and 7 minutes.The mean percentage viability of test item treated tissues was 45.7 which were <50% of the negative control, hence the test item is considered as irritantand the mean percentage viability of positive controltreated tissues was 4.4 which were <50% of the negative control clearly represents the irritation potential of positive control.

Endpoint:
skin corrosion: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
02 December 2021 to 08 June 2022
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
OECD 431
Qualifier:
according to guideline
Guideline:
OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
GLP compliance:
yes (incl. QA statement)
Remarks:
GLP Certificate
Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
other: MatTek in vitro Life Science Laboratories
Justification for test system used:
The Reconstructed Human Epidermal Model EpiDerm™ (EPI-200-SCT) was selected as test system to assess the skin corrosion potential of the test item as it represents a recommended in vitro test system according to OECD Guideline No. 431.
Vehicle:
unchanged (no vehicle)
Details on test system:
OECD 431
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
25 mg
Duration of treatment / exposure:
3 minutes and 1 hour
Number of replicates:
2
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean of two replicates for 3 min exposure
Value:
100.5
Vehicle controls validity:
not examined
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean of 2 replicates of 1 h exposure
Value:
89.5
Vehicle controls validity:
not examined
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Interpretation of results:
GHS criteria not met
Conclusions:
Based on the results obtained under the conditions of this study, the test item is considered as non-corrosive in accordance with UN GHS, as the mean percentage tissue viability was greater than 50% after 3 minutes exposure and greater than 15% after 1 hour exposure of the negative control.
Executive summary:

The mean OD of the negative control tissues was 2.537 (3 minutes exposure) and 2.208 (1 hour exposure) which was within the range of ≥0.8 and ≤2.8, hence the tissues were considered as viable after shipping and storing procedures and under specific conditions of use. Percentage viability of tissues was measured by performing MTT assay after 3 minutes and 1 hourof treatment. The mean percentage viability of test item treated tissues was 100.0% after 3 minutes of exposure which were >50% and 100.0% after 1 hour of exposure which were >15% of the negative control hence the test item is considered as non-corrosive.The mean percentage viability of positive controltreated tissues was 2.5% after 3 minutes and 2.1% after 1 hour exposure which were <15% of the negative control clearly represents the irritation potential of positive control.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Eye irritation

Link to relevant study records

Referenceopen allclose all

Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
19 December 2020 to 04 January 2021
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Justification for type of information:
Since results of an ex vivo study on eye irritation indicated equivocal results and no stand-alone prediction can be made, a subsequent in vivo study was needed to fulfill the data requirements.
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
Version / remarks:
(Section 4: Health Effects), “Acute Eye Irritation/Corrosion” adopted on 09 October 2017 (Corrected on 26 June 2020)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Batch No.of test material: EX. 14402. 600
- Expiration date of the batch: No change of properties known over time (endless)

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Ambient (21 to 29°C)
Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Source: Adita Biosys Private Limited
- Age at study initiation: 4 months
- Weight at study initiation: 2.39066 kg to 2.42196 kg
- Housing: stainless steel wire mesh cage L 24 x B 18 x H 18 inches
- Diet (e.g. ad libitum): Altromin Maintenance diet for rabbits – Rich in crude fibre 2123
- Water (e.g. ad libitum): Deep bore-well water passed through reverse osmosis unit
- Acclimation period: Start: 21 December 2020 End: 31 December 2020

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.3°C to 22.8°C
- Humidity (%): 47% to 67%
- Air changes (per hr): 12 to 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours fluorescent light and 12 hours dark cycle

IN-LIFE DATES: From: 26 December 2020 To: 04 January 2021
Vehicle:
unchanged (no vehicle)
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (weight with unit): Initial test: 45.2 mg and Confirmatory test: 47.6 mg and 49.1 mg


Duration of treatment / exposure:
1 hour
Observation period (in vivo):
1, 24, 48 and 72 hour
Number of animals or in vitro replicates:
3 (1 for initial test, 2 for confirmatory test)
Details on study design:
REMOVAL OF TEST SUBSTANCE
- Washing: The eye was rinsed using 0.9% w/v normal saline after 1 hour treatment (post treatment)
- Time after start of exposure: 1 hour post test item instillation

SCORING SYSTEM: Cornea, area of cornea involved, iris, conjuctivae and chemoses was scored after 1, 24, 48 and 72 hour post test item instillation all with a maximum score of 4

TOOL USED TO ASSESS SCORE: hand-slit lamp and fluorescein
Irritation parameter:
cornea opacity score
Basis:
mean
Time point:
24/48/72 h
Score:
0
Max. score:
4
Reversibility:
fully reversible
Irritation parameter:
iris score
Basis:
mean
Time point:
24/48/72 h
Score:
0
Max. score:
4
Reversibility:
fully reversible
Irritation parameter:
conjunctivae score
Basis:
mean
Time point:
24/48/72 h
Score:
0.33
Max. score:
4
Reversibility:
fully reversible
Irritation parameter:
chemosis score
Basis:
mean
Time point:
24/48/72 h
Score:
0.33
Max. score:
4
Reversibility:
fully reversible
Other effects:
- Lesions and clinical observations: No clinical signs of toxicity and mortality were observed in both initial and confirmatory test animals

In both initial and confirmatory test, treated eye (left) revealed occular lesions like redness [Some blood vessels hyperaemic (injected)] at 1, 24 and 48 hour observation and chemosis (Some swelling above normal) at 24 hour observation. The observed lesion reversed back to normal by 72 hour observation

In both initial and confirmatory test, ocular lesion like conjunctivitis were observed at 24 and 48 hour observation. No ocular lesion was observed at 72 hour observation during slit lamp examination

- Effects of rinsing or washing: no effects on the eye due to washing

             TABLE 1. INDIVIDUAL ANIMAL CLINICAL SIGNS OF TOXICITY AND MORTALITY RECORD

Phase of the Experiment

Dose (mL/animal)

Animal No.

Sex

Clinical Signs of Toxicity and Mortality on Day

1

2

3

4

#

*

#

*

#

*

#

Initial Test

0.1

Nb5987

M

N

N

N

N

N

N

N

Confirmatory Test

0.1

Nb5988

M

N

N

N

N

N

N

N

0.1

Nb5989

M

N

N

N

N

N

N

N

           M: Male; N: Normal; #: First observation; *: Second observation


            TABLE 2. INDIVIDUAL ANIMAL EYE IRRITATION/CORROSION SCORING RECORD

Chemosis

Opacity

Area

Eyes

LE

RE

LE

RE

LE

RE

LE

RE

LE

RE

1 hr

1

0

0

0

0

0

0

0

-

-

24 hrs

1

0

1

0

0

0

0

0

-

-

48 hrs

1

0

0

0

0

0

0

0

-

-

72 hrs

0

0

0

0

0

0

0

0

-

-

Mean Tissue Score

0.67

0

0.33

0

0

0

0

0

-

-


hr: hour; hrs: hours; LE: Left Eye (Treated Eye); RE: Right Eye (Untreated/Reference control Eye);

Mean Tissue Score = (24 hr+48 hr+72 hr)/3

Redness: 0: Normal; 1: Some blood vessels hyperaemic (injected)

Chemosis:0: Normal; 1: Some swelling above normal

Iris:0: Normal               

Opacity:0: No ulceration or opacity

 


TABLE 2 (Contd...).  INDIVIDUAL ANIMAL EYE IRRITATION/CORROSION SCORING RECORD

Confirmatory Test                           Sex: Male                     Dose: 0.1 mL/animal      Animal No.:Nb5988

Observation Period

Ocular Lesions

Conjunctiva

Iris

Cornea

Redness

Chemosis

Opacity

Area

Eyes

LE

RE

LE

RE

LE

RE

LE

RE

LE

RE

1 hr

1

0

0

0

0

0

0

0

-

-

24 hrs

1

0

1

0

0

0

0

0

-

-

48 hrs

1

0

0

0

0

0

0

0

-

-

72 hrs

0

0

0

0

0

0

0

0

-

-

Mean Tissue Score

0.67

0

0.33

0

0

0

0

0

-

-

 

 

Confirmatory Test                           Sex: Male                     Dose: 0.1 mL/animal      Animal No.:Nb5989

Observation Period

Ocular Lesions

Conjunctiva

Iris

Cornea

Redness

Chemosis

Opacity

Area

Eyes

LE

RE

LE

RE

LE

RE

LE

RE

LE

RE

1 hr

1

0

0

0

0

0

0

0

-

-

24 hrs

1

0

1

0

0

0

0

0

-

-

48 hrs

1

0

0

0

0

0

0

0

-

-

72 hrs

0

0

0

0

0

0

0

0

-

-

Mean Tissue Score

0.67

0

0.33

0

0

0

0

0

-

-

hr: hour; hrs: hours; LE: Left Eye (Treated Eye); RE: Right Eye (Untreated/Reference control Eye)

Mean Tissue Score = (24 hr+48 hr+72 hr)/3

Redness: 0: Normal; 1: Some blood vessels hyperaemic (injected)

Chemosis:0: Normal; 1: Some swelling above normal

Iris:0: Normal               

Opacity:0: No ulceration or opacity

                                       TABLE 3.  INDIVIDUAL ANIMAL SLIT LAMP EXAMINATION RECORD

Initial Test                   Sex: Male                       Dose: 0.1 mL/animal                         Animal No.: Nb5987

 

Day 2

(24 hours)

Day 3

(48 hours)

Day 4

(72 hours)

Eye

LE

RE

LE

RE

LE

RE

Lids

13

N

13

N

N

N

Ducts

N

N

N

N

N

N

Cornea

N

N

N

N

N

N

Pupil

N

N

N

N

N

N

Sclera

N

N

N

N

N

N

Ciliary Bodies

N

N

N

N

N

N

Iris

N

N

N

N

N

N

Aqueous Humour

N

N

N

N

N

N

Lens

N

N

N

N

N

N

Vitreous Humour

N

N

N

N

N

N

LE: Left Eye; RE: Right Eye; N: Normal/No Abnormality Detected; 13: Conjunctivitis

 

  


TABLE 3 (Contd…). INDIVIDUAL ANIMAL SLIT LAMP EXAMINATION RECORD

Confirmatory Test                   Sex: Male                       Dose: 0.1 mL/animal            Animal No.: Nb5988

 

Day 2

(24 hours)

Day 3

(48 hours)

Day 4

(72 hours)

Eye

LE

RE

LE

RE

LE

RE

Lids

13

N

13

N

N

N

Ducts

N

N

N

N

N

N

Cornea

N

N

N

N

N

N

Pupil

N

N

N

N

N

N

Sclera

N

N

N

N

N

N

Ciliary Bodies

N

N

N

N

N

N

Iris

N

N

N

N

N

N

Aqueous Humour

N

N

N

N

N

N

Lens

N

N

N

N

N

N

Vitreous Humour

N

N

N

N

N

N

 

 

Confirmatory Test                   Sex: Male                       Dose: 0.1 mL/animal            Animal No.: Nb5989

 

Day 2

(24 hours)

Day 3

(48 hours)

Day 4

(72 hours)

Eye

LE

RE

LE

RE

LE

RE

Lids

13

N

13

N

N

N

Ducts

N

N

N

N

N

N

Cornea

N

N

N

N

N

N

Pupil

N

N

N

N

N

N

Sclera

N

N

N

N

N

N

Ciliary Bodies

N

N

N

N

N

N

Iris

N

N

N

N

N

N

Aqueous Humour

N

N

N

N

N

N

Lens

N

N

N

N

N

N

Vitreous Humour

N

N

N

N

N

N

LE: Left Eye; RE: Right Eye; N: Normal/No Abnormality Detected; 13: Conjunctivitis

 

   TABLE 4.   INDIVIDUAL ANIMAL BODY WEIGHT (kg) AND PERCENT CHANGE IN BODY WEIGHT WITH RESPECT TO DAY 1

Phase of the Experiment

 

Dose (mL/animal)

Animal No.

Sex

Body Weight (kg) on Day

Percent Change in Body Weight with Respect to Day

1

4

1 to 4

Initial Test

0.1

Nb5987

Male

2.47619

2.51406

1.52937

Confirmatory Test

0.1

Nb5988

Male

2.49617

2.52473

1.14415

0.1

Nb5989

Male

2.51403

2.54009

1.03658

 

 

 

Mean

2.50510

2.53241

1.09037

 

 

 

±SD

0.01263

0.01086

0.07606

 

 

 

n

2

2

2

 SD: Standard deviation; n: Number of animals

Interpretation of results:
GHS criteria not met
Conclusions:
Based on the above results of the experiment and under the experimental conditions employed, it is concluded that the mean score of the test item does not meet classification criteria and hence not classified or categorized as per the Globally Harmonized System of Classification and Labelling of Chemicals (GHS).
Executive summary:

The test item was evaluated for Acute Eye Irritation/Corrosion in New Zealand White Rabbits.


The study was performed in two phases i.e., initial and confirmatory tests. Both the eyes of each experimental animal was examined within 24 hours before the treatment. The animals with absence of signs of eye irritation, ocular defects or pre-existing corneal injury were used for the treatment. The pH of test item was 3.08 as per in-house pH determination.


 


The initial test was conducted using single male rabbit and confirmatory test was conducted using two male rabbits. The systemic analgesic (tramadol hydrochloride injection 2.5 mg/kg) and two drops of topical ocular anaesthetic (0.5% tetracaine hydrochloride) were given to each animal sixty minutes and five minutes prior to test item instillation respectively. The 0.1 mL (Initial test: 45.2 mg and Confirmatory test: 47.6 mg and 49.1 mg) of test item was instilled into the conjunctival sac of the left eye and right eye served as control. The eyes were scored approximately at 1, 24, 48 and 72 hours. Slit lamp examination was carried out using fluorescein strips (fluorescein sodium ophthalmic strip USP) and were scored approximately at 24, 48 and 72 hours for both initial and confirmatory test.


 


All the animals (initial test and confirmatory test) were observed twice daily for clinical signs of toxicity and mortality. No treatment related clinical signs of toxicity and mortality were observed in all the animals (initial and confirmatory tests) after the test item instillation.


 


In both initial and confirmatory test, treated eye (left) revealed occular lesions like redness at 1, 24 and 48 hour; chemosis at 24 hour observation. The observed lesion reversed back to normal by 72 hour observation.


 


In both initial and confirmatory test, ocular lesion like conjunctivitis were observed at 24 and 48 hour observation. No ocular lesion was observed at 72 hour observation during slit lamp examination.


 


The body weight was recorded on the day of receipt, on the day of treatment (prior to instillation of test item) and at termination of the experiment. No changes were noted in body weight and percent change in body weight with respect to day 1 in both initial and confirmatory test. All the animals revealed physiologically normal increase in body weight in both initial and confirmatory tests.


 


All the animals were sacrificed by intravenous administration of sodium thiopentone and carcass was disposed.


 


For initial test and confirmatory test, the mean score calculated across 3 scoring times (approximately 24, 48 and 72 hours after test item instillation) for cornea, iris and conjunctival redness and conjunctival chemosis were 0, 0, 0.67 and 0.33 respectively

Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From 03 November 2020 to 02 December 2020
Reliability:
1 (reliable without restriction)
Qualifier:
according to guideline
Guideline:
OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
Version / remarks:
26 June 2020
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
The Study No. BIO-ALT 047, entitled “Bovine Corneal Opacity and Permeability Test of Mo10V3TeNbO42” was performed in compliance with the OECD Principles of Good Laboratory Practice [C(97)186/Final]
Species:
cattle
Details on test animals or tissues and environmental conditions:
Justification for selection of Test system: Cornea of the cattle is the recommended test system in the guideline.
Vehicle:
water
Remarks:
Name : Distilled water
Controls:
yes, concurrent vehicle
yes, concurrent positive control
Amount / concentration applied:
G1 Vehicle Control 750 µL of distilled water -
G2 Positive Control 750 µL of Imidazole 20% w/v
G3 Test Item 750 µL of test item 20% w/v
Duration of treatment / exposure:
3 hours and 55 minutes
Duration of post- treatment incubation (in vitro):
3 hours and 55 minutes
Number of animals or in vitro replicates:
3
Details on study design:
NUMBER OF REPLICATES: 3

SOLVENT CONTROL USED: water

POSITIVE CONTROL USED: Imidazole

APPLICATION DOSE AND EXPOSURE TIME: 20 % w/v, 3 h 55 min

TREATMENT METHOD: closed chamber

POST-INCUBATION PERIOD: no

REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: with EMEM (with phenol red) until no visual evidence of the test item was apparent. Subsequent washing step with MEM without phenol red

METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: opacitometer
- Corneal permeability: passage of sodium fluorescein dye measured with the aid of UV/VIS spectrophotometry at 49 0nm
- Other: Histopathological evaluation

SCORING SYSTEM: In Vitro Irritancy Score (IVIS)

DECISION CRITERIA: IVIS ≤ 3 considered as UN GHS no category. IVIS score, >3 and ≤ 55 considered as equivocal, subsequently testing with any other adequate method needed. IVIS > 55 considered as severe irritant causing serious eye damage and classified as UN GHS category 1 without further testing.
Irritation parameter:
cornea opacity score
Run / experiment:
mean of three replicates
Value:
44.89
Vehicle controls validity:
valid
Remarks:
Distilled water
Negative controls validity:
not examined
Positive controls validity:
valid
Remarks:
Imidazole
Remarks on result:
positive indication of irritation
Irritation parameter:
fluorescein leakage
Remarks:
Corrected Permeability Value
Run / experiment:
Mean of 3 replicates
Value:
0.009
Vehicle controls validity:
valid
Remarks:
distilled water
Negative controls validity:
not examined
Positive controls validity:
valid
Remarks:
Imidazole
Remarks on result:
no indication of irritation
Irritation parameter:
histopathological observations
Run / experiment:
observations in thrre replicates
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
The results indicated an increase in the endpoint “opacity” but not “permeability”. As the test item resulted in IVIS >3; ≤ 55, it is considered as equivocal and classified as UN GHS no stand-alone prediction can be made. Hence, further testing is needed.

  • SUMMARY OF IN VITRO OPACITY SCORE


               Refer Appendix - 2, 3 & 4










































































































Group & Treatment



Initial Opacity Reading (I)



Opacitometer Reading (After Treatment)



Change in Opacity Value



Corrected Opacity Value



Average of Permeability Value



Corrected Permeability Value



Individual IVIS Value



Mean of Corrected Opacity Value



Corrected Permeability Value



IVIS Value



G1 & Vehicle Control



6.073



6.164



0.091



1.094



0.060



0.061



-



-



-



-



6.256



6.905



0.649



0.062



6.119



8.662



2.543



0.061



G2 & Positive  Control



6.301



132.116



125.815



124.720



1.636



1.575



148.3



120.34



1.573



143.9



5.983



113.696



107.713



106.619



1.634



1.573



130.2



5.983



136.752



130.769



129.675



1.632



1.571



153.2



G3 &Test Item



6.439



48.667



42.228



41.133



0.051



-0.010



41.0



44.89



-0.009



44.8



6.717



52.204



45.487



44.393



0.053



-0.008



44.3



6.393



56.641



50.248



49.153



0.052



-0.009



49.0



IVIS: In Vitro Irritancy Score.


 


Note:


Change in Opacity Value = Opacity reading (after treatment) - initial opacity reading (I).


Corrected Opacity Value = Change in opacity value of positive/test item – mean change in opacity value of vehicle control.


Corrected Permeability Value = Average of permeability value of positive/test item - mean Average of permeability value of vehicle control.



  • INDIVIDUAL DATA OF ANIMAL AGE AND SEX



















































Sl. No.



Approximate Age (Years)



Sex



1



4.0



Female



2



4.5



Male



3



3.5



Female



4



4.0



Male



5



4.5



Male



6



3.5



Female



7



4.0



Male



8



4.5



Male




  • INDIVIDUAL DATA OF SELECTION AND DISTRIBUTION OF CORNEAS


Initial Reading of Empty Cornea Holder with Media





































































































































































Cornea Holder No.



Opacitometer I0 Value



Mean I0 Value



1



1134



1145



2



1180



4



1174



5



1105



6



1167



7



1168



8



1177



9



1204



10



1168



12



1189



14



1108



15



1192



17



1094



18



1010



20



1109



 


Opacity Reading (Before Treatment)



Corneal Holder No.



Initial Opacitometer Reading (I)



Opacity=I0/I



Opacity Value


[= (I0/I-b)/a]



1



998



1.148



6.3



2



1005



1.140



6.0



4



854



1.341



14.0



5



742



1.543



22.1



6



1002



1.143



6.1



7



995



1.151



6.4



8



586



1.954



38.4



9



989



1.158



6.7



10



698



1.641



26.0



12



1003



1.142



6.1



14



657



1.743



30.0



15



996



1.150



6.4



17



1005



1.140



6.0



18



999



1.146



6.3






















































































APPENDIX 2 (Contd…) INDIVIDUAL DATA OF SELECTION AND DISTRIBUTION OF CORNEAS


Selection and Distribution of Cornea - Before Treatment


      

Corneal Holder No.



Group & Treatment



Initial Opacitometer Reading (I) Before Treatment



Opacity=I0/I



Opacity Value


 (= (I0/I-b)/a)



Mean Opacity Value



12



G1 & Vehicle Control



1003



1.142



6.0734



6.1



18



999



1.146



6.2555



6



1002



1.143



6.1188



1



G2 & Positive  Control



998



1.148



6.3013



6.1



2



1005



1.140



5.9828



17



1005



1.140



5.9828



7



G3 & Test Item



995



1.151



6.4391



6.5



9



989



1.158



6.7173



15



996



1.150



6.3931



 a=0.0251, b=0.9894, I0=1145



  • INDIVIDUAL DATA OF OPACITY READINGS










































































Group & Treatment



Corneal  Holder No.



Opacitometer Reading


(After Treatment)



Opacity=I0/I



Opacity Value            (= (I0/I-b)/a)



Mean Opacity Value



G1 & Vehicle Control



12



1001



1.144



6.164



7.24



18



985



1.163



6.905



6



949



1.207



8.662



G2 & Positive  Control



1



266



4.306



132.116



127.52



2



298



3.843



113.696



17



259



4.422



136.752



G3 &Test Item



7



518



2.211



48.667



52.50



9



498



2.300



52.204



15



475



2.411



56.641



  I0=1145 a=0.0251, b=0.9894



  • INDIVIDUAL PERMEABILITY VALUES


After Treatment


 














































































Group & Treatment



Replicate



Permeability OD490 value



Average  Permeability



G1 & Vehicle Control



R1



0.059



0.062



0.060



0.060



R2



0.061



0.061



0.064



0.062



R3



0.062



0.059



0.062



0.061



G2 & Positive  Control



R1



1.632



1.628



1.648



1.636



R2



1.638



1.632



1.633



1.634



R3



1.636



1.638



1.623



1.632



G3 & Test Item



R1



0.050



0.052



0.052



0.051



R2



0.053



0.054



0.051



0.053



R3



0.053



0.052



0.052



0.052



    R=Replicates, IVIS= Mean opacity Value + (15×Mean Permeability OD490 value)



  • MICROSCOPIC OBSERVATIONS OF BOVINE CORNEAS

















































































Group



Group Description (Treatment)



Corneal Holder No.



Observations



G1



Vehicle Control (Distilled water)



6



NAD



12



NAD



18



NAD



G2



Positive Control (Imidazole)



1



Epithelium:


 



·      Epithelial cell loss, Squamous layer, mf, 3


·      Cytoplasmic coagulation, Squamous and Wing layer, diffuse, 4


·      Cytoplasmic vacuolization, Wing and basal layer, diffuse, 3



Stroma:



·      Collagen matrix expansion, upper stroma, mf, 2



Endothelium:



·      NAD



2



Epithelium:


 



·      Epithelial cell loss, Squamous layer, mf, 3


·      Cytoplasmic coagulation, Squamous and Wing layer, diffuse, 4


·      Cytoplasmic vacuolization, Wing and basal layer, diffuse, 3



Stroma:



·      Collagen matrix expansion, upper stroma, mf, 2



Endothelium:



·      NAD



17



Epithelium:


 



·      Epithelial cell loss, Squamous layer, mf, 3


·      Cytoplasmic coagulation, Squamous and Wing layer, diffuse, 4


·      Cytoplasmic vacuolization, Wing and basal layer, diffuse, 3



Stroma:



·      Collagen matrix expansion, upper stroma, mf, 2



Endothelium:



·      NAD



G3



Test Item (Mo10V3TeNbO42)



07



NAD



09



NAD



15



NAD



 NAD: No abnormalities detected, mf: Multifocal, 2: Mild, 3: Moderate; 4: Marked.

Interpretation of results:
study cannot be used for classification
Remarks:
With in the Bovine Corneal Opacity and Permeability Test, the test item induced an IVIS of 44.8 after 3 hours and 55 minutes of treatment. The results indicated an increase in the endpoint “opacity” but not “permeability”. As the test item resulted in IVIS >3; ≤ 55, it is considered as equivocal and classified as UN GHS no stand-alone prediction can be made.
Conclusions:
Based on the results obtained in the Bovine Corneal Opacity and Permeability Test, the test item induced an IVIS of 44.8 after 3 hours and 55 minutes of treatment. The results indicated an increase in the endpoint “opacity” but not “permeability”. As the test item resulted in IVIS >3; ≤ 55, it is considered as equivocal and classified as UN GHS no stand-alone prediction can be made
Executive summary:

Summary


The test item was evaluated for ocular corrosivity or severe irritancy in Bovine cornea.


Eyes of cattle were collected from slaughter house ad eye balls free of defects were selected for the experiment. Empty cornea holder’s opacity was measured and the mean opacity value obtained was determined as I0. Cornea holders with selected Corneas were equilibrated at 32±1ºC for 1 hour and baseline opacity was recorded for each cornea. Corneas with opacity units less than 7 were selected and used for the study.


Quantity of 750 µL 20% w/v of test item, distilled water (vehicle control) and 20% w/v imidazole (positive control) was introduced into anterior chamber in triplicates to the designated cornea holders and incubated at 32±1ºC for 3 hours and 55 minutes. Opacity was measured with the aid of opacitometer and permeability was determined spectrophotometrically at 490 nm (OD490).


The mean corrected opacity and mean corrected permeability values of test item are 44.89 and -0.009 respectively. The in vitro Irritancy Score (IVIS) of test item resulted in 44.8 considered as equivocal, no stand-alone prediction can be made.


The mean corrected opacity and mean corrected permeability values of positive control are 120.34 and 1.573 respectively. The in vitro Irritancy Score (IVIS) of positive control resulted in 143.9, indicating corrosivity or severe irritancy to Bovine corneas.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

The OECD TG 431 revealed a mean percentage of viability of 100 % after 3 minutes and 1 hour. 


In conclusion, the combination of both OECD TG studies identified the test material as skin irritant category 2.


In regard of eye irritation, OECD TG 437 induced an ICIS of 44.8 after 3 h 55 min, The results indicated an increase in the endpoint "opacity" but not "permeability". As the test item resulted in IVIS > 3 <= 55, it is considered as equivocal and classification according to GHS got not be made as stand alone assay. Hence, a OECD TG 405 was performed. Within this study, both inital and confirmatory test revealed iccular lesions like redness at 1, 24 and 48 h as well as chemosis at 24 h. All effects were reversible after 72 h. Further, noth tests revealed ocular lesion like conjuctivitis at 24 and 48 h, which was reversible after 72 h as well. All in all the mean scoring for cornea, iris and conjuctival redness as well as conjuctival chemosis were 0, 0, 0.67, and 0.33 respectively. Due to the low degree of scores and reversible effects, no classification according to GHS is justified.